FDA Approves Continuous Sub-Q Tx for Parkinson’s – Onapgo
Following what seems to be a new trend, the FDA has approved yet another 20+ year old therapy based on a major remodel… this one
April 25, 2025
Following what seems to be a new trend, the FDA has approved yet another 20+ year old therapy based on a major remodel… this one
The FDA recently approved a new therapy originally approved in 2006, Susvimo (ranibizumab) from Genentech, an ocular implant providing customized therapy for diabetic macular edema
The FDA recently approved another biosimilar, Avtozma (tocilizumab-anoh) from Celltrion, as a third biosimilar to Actemra. As with the reference brand, Avtozma is indicated for the
The FDA recently approved a very old drug, Spravato (esketamine) from Janssen Pharmaceuticals, for a very new indication. Esketamine was originally approved by the FDA
Announcements for newly approved specialty drugs often state that the product will be available through specialty pharmacy in limited distribution. However, the early press releases
How well do you understand cell based therapy? It’s complicated! Given the pace of research and the number of already approved cell-based products it is
Quiz me this…..! What new technology emerged in the 1970s that truly changed the world?…. Certainly, you immediately thought of ‘the computer’ in your top 5
…………. catching up on recent FDA approvals The FDA recently approved a new therapy, Crenessity (crinecerfont) from Neurocrine Biosciences, Inc., to be used together with glucocorticoids
…………………. catching up on recent FDA approvals The FDA recently approved a new infused therapy, Bizengri (zenocutuzumab-zbco) from Merus N.V., indicated for adults with pancreatic adenocarcinoma
The FDA recently approved a biosimilar, Yesintek (Ustekinumab-kfce) from Biocon Biologics Ltd, as a biosimilar to the reference product, Stelara (Ustekinumab). This approval is the
